Bulacan State University

COLLEGE OF NURSING
City of Malolos, Bulacan

DRUG STUDY
Patient’s Initial: ___________
L.M. Age: ____36____ F
Gender: ________ 11/22/2019
Date Handled: _________________
NSD
Medical Diagnosis: _______________________________ Chief Complaint: Pain
_________________________
related to episiotomy wound Clinical Area: __________________
OB WARD (BMC)

DRUG DATA CLASSIFICATION MECHANISM OF INDICATIONS CONTRAINDICATIONS ADVERSE EFFECT NURSING

ACTION RESPONSIBILITIES
Generic name: Therapeutic: Causes potent and General: Precaution: CNS: subarachnoid Before:
oxytocin Oxytocics selective  To induce or  Contraindicated hemorrhage,  Explain use
(synthetic stimulation of stimulate labor in patients seizures. and
injection) uterine and Adults: Initially, 0.5 to 1 hypersensitive to CV: arrhythmias, administratio
Pregnancy mammary gland milliunit/minute I.V. drug. HTN, OVCs n of drug to
Trade name: Category Risk: smooth muscle. infusion. Increase rate  Contraindicated GI: abruption, patient and
Pitocin Category X by 1 or 2 milliunit/minute when vaginal placentae, tetanic family.
at 30-60 minute delivery isn’t uterine contractions,
Patient’s dose: intervals until normal advised postpartum During:
20 mL contraction pattern is (placenta previa, hemorrhage, uterine  Instruct
(20gtts/min) for established. Decrease vasa previa, rupture, impaired patient to
24 hrs rate when labor is firmly invasive cervical uterine blood flow, promptly
established. Rates carcinoma, pelvic hematoma, report
Route: exceeding 9-10 genital herpes), increased uterine adverse
I.V. milliunits/minute are when motility. reactions
rarely required. cephalopelvic Hematologic: (site irritation,
disproportion is afibrinogenemia, nausea,
 To reduce present, or when possibly related to bleeding,
postpartum delivery requires postpartum bleeding blurred
bleeding after conversion, as in Other: anaphylaxis, vision,
expulsion of transverse lie. death from oxytocin difficulty
placenta  Contraindicated induced water speaking,
Adults: 10 to 40 units in in fetal distress intoxication, wheezing,
1, 000 ml of D5 w when delivery hypersensitivity itching,
injection, lactated isn’t imminent, in reactions. swelling)
Ringer solution, or NSS prematurity, in
I.V. infused at rate other obstetric FETAL
needed to sustain emergencies, CNS: infant brain
uterine contraction and and in patient damage, seizure After:
control uterine atony. with severe CV: bradycardia,
Also, may give 10 units toxemia or arrhythmias, PVCs.
I.M. after delivery of hypertonic EENT: neonatal
placenta. uterine patterns. retinal hemorrhage.
 Use cautiously, Hepatic: neonatal
 Incomplete, if at all, in jaundice
inevitable, or patients with Other: lower apgar
elective abortion invasive cervical score at 5 minutes,
Adults: 10 units I.V. cancer and in death.
infusion at 10-20 those with
milliunits (20-40 drops) / previous cervical
minute. Don’t exceed 30 or uterine
units in 12 hours. surgery
(including
cesarean
section). Grand
multipartiy,
uterine sepsis,
traumatic
delivery, or over
distended
uterus.
 Alert: May
cause
antidiuretic
effects and risk
of sever water
intoxication,
seizures, or
death,
particularly with
large doses or
when patient is
receiving fluids
by mouth.
 Dialyzable
drug: unknown
 Overdose:
Uterine
hypersensitivity,
tumultuous
labor, uterine
rupture, cervical
and vaginal
lacerations,
postpartum
hemorrhage,
uteroplacental
hypoperfusion,
variable
deceleration of
fetal HR, fetal
hypoxial
hypercapnia,
perinatal hepatic
necrosis, water
intoxication,
seizures, death.